The College of Medicine and Veterinary Medicine at The University of Edinburgh is an international leader in basic-to-clinical translational research.
Our approach ranges from molecules to man, from bench to bedside, and from process to population. Our interdisciplinary groups, centres and institutes bring together basic and clinical academic staff in broad, thematic research concentrations encompassing basic sciences, translational and clinical research. Research within the College explicitly links biomedicine and veterinary medicine, in promotion of the concept 'One Medicine'.
High calibre graduates are invited to apply for funded PhDs for September 2017 entry across our world-leading research institutes, centres and doctoral training programmes:
In our Interdisciplinary Research Centres, critical masses of clinical and basic scientists interact closely around their basic-to-translational goals, overcoming boundaries between "wet" and "dry" science and primary and secondary care, adding substantial value and offering the finest research training environments.
The excellence of these Centres is evidenced by prestigious external funding awards including: 4 Medical Research Council (MRC) Centres, 2 British Heart Foundation (BHF) Centres, a Cancer Research UK (CRUK) Centre, an Asthma UK (A-UK) Centre for Applied Research, a BBSRC Strategically funded institute (The Roslin Institute), an MRC University Unit (Human Genetics Unit) and a World Health Organisation (WHO) Collaborating Centre on Population Health Research and Training. In addition to these, the Wellcome Trust has just awarded funding for 4 year PhDs in Translational Neuroscience and Tissue Repair.
The University of Edinburgh is a leading postgraduate teaching and research centre, ranked 19th in the QS World Rankings 2016/17, 7th in Europe, 5th in the UK and 1st in Scotland.
The College’s reputation as one of the world’s leading centres of medical and veterinary medical research has been reaffirmed by its UK REF 2014 results.
The deadline for the majority of PhD Studentships for 2017/18 entry is end of January 2017 - we usually start accepting applications for these funded PhDs in November/December. Please visit each Research Centre or DTP website (listed above) and live PhD projects (listed below) for specific deadlines.
|Adhesion protein biology in human pancreatic cancer||Details|
|Can Biotin alter the decline of physical function, fatigue and fatigability of people with early progressive MS?||Details|
|Characterization of Actin Dynamics and Photoreceptor Dysfunction in Retinitis Pigmentosa||Details|
|Chromatin architecture of the developing limb||Details|
|Determining the effects of mutations on the epigenome in cancer||Details|
|How do science and society shape each other? An analysis of the choreography and consequences of engagements between research and advocacy in the case of MND||Details|
|Identification of the cell of origin in MLL-AF9-associated infant leukaemia||Details|
|Imaging developmental gene regulation in living mammalian cells||Details|
|Living with Paediatric MS: The Experiences of Children and Their Families||Details|
|Magnetisation transfer imaging biomarkers of demyelination and remyelination in MS||Details|
|Modelling systemic molecular changes underlying prognosis in lung cancer||Details|
|Nonsense-mediated decay pathway in the Endoplasmic reticulum (ER-NMD)||Details|
|Single cell genomic characterization of tumor microenvironment||Details|
|Super-resolution imaging of maturing heterochromatin states in developing embryos and stem cells||Details|
|The impact of screening for cognitive and behavioural change in Motor Neurone Disease||Details|
|The role of transcription factor Pax6 in determining glutamatergic versus GABAergic cell fate in developing mammalian cerebral cortex||Details|
|Understanding how progenitor cell-niche interactions alter during development and with adult ageing through Next-Generation techniques||Details|
|Understanding the function of new autophagy players and their relevance in brain tumours||Details|
|Using CRISPR/Cas9 gene editing to protect motor neurons||Details|
|No Live Listings|